Bank of America’s Sonoma Pharmaceuticals SNOA Stock Holding History

Bank of America’s Portfolio SNOA Stock Details SNOA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-18	Closed	-$65	–	6742
2025 Q4	$65	Buy	18 +1	+6%	+$4	﹤0.01%	6914
2025 Q3	$66	Hold	17	–	–	﹤0.01%	7948
2025 Q2	$49	Buy	17 +2	+13%	+$6	﹤0.01%	8110
2025 Q1	$32	Buy	15 +3	+25%	+$8	﹤0.01%	8056
2024 Q4	$32	Buy	12 +9	+300%	+$25	﹤0.01%	7943
2024 Q3	$9	Sell	3 -6	-67%	-$31	﹤0.01%	8054
2024 Q2	$36	Buy	9 +7	+350%	+$25	﹤0.01%	7905
2024 Q1	$7	Hold	2	–	–	﹤0.01%	7569
2023 Q4	$8	Hold	2	–	–	﹤0.01%	7813
2023 Q3	$34	Hold	2	–	–	﹤0.01%	7538
2023 Q2	$47	Hold	2	–	–	﹤0.01%	7470
2023 Q1	$43	Hold	2	–	–	﹤0.01%	7528
2022 Q4	$49	Hold	2	–	–	﹤0.01%	7799
2022 Q3	$0	Sell	2 -369	-99%	-$21.6K	﹤0.01%	8168
2022 Q2	$22K	Buy	371 +369	+18,450%	+$23.6K	﹤0.01%	7161
2022 Q1	$0	Hold	2	–	–	﹤0.01%	8711
2021 Q4	$0	Hold	2	–	–	﹤0.01%	8601
2021 Q3	$0	Sell	2 -1	-33%	-$123	﹤0.01%	8367
2021 Q2	$0	Sell	3 -8	-73%	-$1.26K	﹤0.01%	8058
2021 Q1	$1K	Buy	11 +9	+450%	+$1.46K	﹤0.01%	7338
2020 Q4	$0	Hold	2	–	–	﹤0.01%	7345
2020 Q3	$0	Sell	2 -1	-33%	-$154	﹤0.01%	7147
2020 Q2	$0	Buy	3 +1	+50%	+$120	﹤0.01%	7106
2020 Q1	$0	Sell	2 -1	-33%	-$101	﹤0.01%	7209
2019 Q4	$0	Sell	3 -1	-25%	-$100	﹤0.01%	7371
2019 Q3	$0	Buy	4 +1	+33%	+$129	﹤0.01%	7480
2019 Q2	$0	Hold	3	–	–	﹤0.01%	7393
2019 Q1	$0	Hold	3	–	–	﹤0.01%	7391
2018 Q4	$0	Sell	3 -1	-25%	-$199	﹤0.01%	7357
2018 Q3	$1K	Buy	4 +1	+33%	+$363	﹤0.01%	7147
2018 Q2	$1K	Hold	3	–	–	﹤0.01%	6985
2018 Q1	$2K	Hold	3	–	–	﹤0.01%	6909
2017 Q4	$3K	Sell	3 -2	-40%	-$1.71K	﹤0.01%	6822
2017 Q3	$5K	Hold	5	–	–	﹤0.01%	6739
2017 Q2	$7K	Sell	5 -2	-29%	-$2.47K	﹤0.01%	6523
2017 Q1	$10K	Buy	7 +2	+40%	+$2.33K	﹤0.01%	6542
2016 Q4	$5K	Buy	+5	New	+$4.14K	﹤0.01%	6708
2016 Q2	–	Sell	-5	Closed	-$5K	–	7350
2016 Q1	$5K	Sell	5 -3	-38%	-$2.79K	﹤0.01%	6577
2015 Q4	$8K	Buy	8 +1	+14%	+$1.07K	﹤0.01%	6752
2015 Q3	$8K	Buy	7 +5	+250%	+$5.93K	﹤0.01%	6644
2015 Q2	$3K	Hold	2	–	–	﹤0.01%	6974
2015 Q1	$2K	Sell	2 -3	-60%	-$2.55K	﹤0.01%	6705
2014 Q4	$6K	Hold	5	–	–	﹤0.01%	7228
2014 Q3	$10K	Hold	5	–	–	﹤0.01%	7325
2014 Q2	$13K	Hold	5	–	–	﹤0.01%	7369
2014 Q1	$16K	Hold	5	–	–	﹤0.01%	7010
2013 Q4	$16K	Hold	5	–	–	﹤0.01%	7122
2013 Q3	$12K	Buy	+5	New	+$12.2K	﹤0.01%	7103
2013 Q2	–	Hold	0	–	–	–	7758

Other funds holding SNOA

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

DRW Securities Chicago, Illinois $7.21B AUM 20.54% 1-Year Est. Return

MCWS

McKinley Carter Wealth Services Wheeling, West Virginia $1.94B AUM 20.7% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Bank of America's SNOA Position: Q1 2026 in Review

Bank of America sold out of Sonoma Pharmaceuticals (SNOA) in Q1 2026, closing a stake of 18 shares — an estimated $65 sold.

Bank of America first reported a position in SNOA in Q3 2013 and held it in 48 quarters. The position peaked at $22K in Q2 2022. 17 funds tracked by Wall St. Rank hold SNOA as of Q1 2026.

Bank of America reported no remaining Sonoma Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
Bank of America sold 18 Sonoma Pharmaceuticals shares in Q1 2026, an estimated $65.
Bank of America first reported a position in Sonoma Pharmaceuticals in Q3 2013 and held it in 48 quarters.
Bank of America's Sonoma Pharmaceuticals position peaked at $22K in Q2 2022.
17 funds tracked by Wall St. Rank held Sonoma Pharmaceuticals as of Q1 2026.

Based on Bank of America's 13F filing for Q1 2026, filed 18 May 2026.